169 related articles for article (PubMed ID: 36657386)
1. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns.
Fonseca MM; Mocelin FJ; Grill MH; Gianesini S; Miyake K; Argenta R; Pereira AH
Phlebology; 2023 Apr; 38(3):165-171. PubMed ID: 36657386
[TBL] [Abstract][Full Text] [Related]
2. A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
Nasser MM; Ghoneim BM; Eldaly W; Elmahdy H
J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101874. PubMed ID: 38522666
[TBL] [Abstract][Full Text] [Related]
3. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
[TBL] [Abstract][Full Text] [Related]
4. Case report: Novel leg vein treatment CLaCS guided by augmented reality 11 years follow-up.
Miyake K; Grill MH; Feitoza HSN
J Cosmet Dermatol; 2023 Jun; 22 Suppl 2():16-20. PubMed ID: 37318788
[TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment.
Moreno-Moraga J; Pascu ML; Alcolea JM; Smarandache A; Royo J; David F; Trelles MA
Lasers Med Sci; 2019 Sep; 34(7):1325-1332. PubMed ID: 30707327
[TBL] [Abstract][Full Text] [Related]
8. Sclerosis and the Nd:YAG, Q-switched laser with multiple frequency for treatment of telangiectases, reticular veins, and residual pigmentation.
Cisneros JL; Del Rio R; Palou J
Dermatol Surg; 1998 Oct; 24(10):1119-23. PubMed ID: 9793523
[TBL] [Abstract][Full Text] [Related]
9. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML
Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489
[TBL] [Abstract][Full Text] [Related]
10. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
Trials; 2014 Dec; 15():497. PubMed ID: 25527165
[TBL] [Abstract][Full Text] [Related]
11. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment.
Levy JL; Elbahr C; Jouve E; Mordon S
Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257
[TBL] [Abstract][Full Text] [Related]
12. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
Bertanha M; Jaldin RG; Moura R; Pimenta REF; Mariúba JVO; Lúcio Filho CEP; Alcantara GP; Padovani CR; Yoshida WB; Sobreira ML
JAMA Dermatol; 2017 Dec; 153(12):1249-1255. PubMed ID: 28973414
[TBL] [Abstract][Full Text] [Related]
14. Optimal and safe treatment of spider leg veins measuring less than 1.5 mm on skin type IV patients, using repeated low-fluence Nd:YAG laser pulses after polidocanol injection.
Moreno-Moraga J; Hernández E; Royo J; Alcolea J; Isarría MJ; Pascu ML; Smarandache A; Trelles M
Lasers Med Sci; 2013 May; 28(3):925-33. PubMed ID: 22886138
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
McCoy S; Evans A; Spurrier N
Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
[TBL] [Abstract][Full Text] [Related]
16. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Rao J; Wildemore JK; Goldman MP
Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
[TBL] [Abstract][Full Text] [Related]
17. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
[TBL] [Abstract][Full Text] [Related]
18. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy.
Coles CM; Werner RS; Zelickson BD
Lasers Surg Med; 2002; 30(2):154-9. PubMed ID: 11870796
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous laser treatment of leg veins.
Meesters AA; Pitassi LH; Campos V; Wolkerstorfer A; Dierickx CC
Lasers Med Sci; 2014 Mar; 29(2):481-92. PubMed ID: 24220848
[TBL] [Abstract][Full Text] [Related]
20. State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment.
Miyake RK; Chi YW; Franklin IJ; Gianesini S
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):893-895. PubMed ID: 32179040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
